https://orcid.org/0000-0003-1183-1072
Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sonsoles Tamarit-Sebastian, Francisco Miguel Ferrer-Soler & Alfredo J Lucendo. (2022) Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs 31:2, pages 193-210.
Read now
Read now
Ángel Arias & Alfredo J. Lucendo. (2020) Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians. Expert Review of Gastroenterology & Hepatology 14:11, pages 1069-1082.
Read now
Read now
Salvatore Oliva, Nurit P. Azouz, Laura Stronati & Marc E. Rothenberg. (2020) Recent advances in potential targets for eosinophilic esophagitis treatments. Expert Review of Clinical Immunology 16:4, pages 421-428.
Read now
Read now
Articles from other publishers (8)
Alina Kanikowska, Susanne Janisz, Dorota Mańkowska-Wierzbicka, Marcin Gabryel, Agnieszka Dobrowolska & Piotr Eder. (2022) Management of Adult Patients with Gastrointestinal Symptoms from Food Hypersensitivity—Narrative Review. Journal of Clinical Medicine 11:24, pages 7326.
Crossref
Crossref
R. Duclaux-Loras & A. Belot. (2022) Les biothérapies en pédiatrie. Perfectionnement en Pédiatrie 5:3, pages 193-201.
Crossref
Crossref
Naiya Patel, Aakash Goyal, Ameet Thaker, David Troendle & Christopher Parrish. (2022) A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders. Journal of Pediatric Gastroenterology & Nutrition 75:2, pages 192-195.
Crossref
Crossref
Alfredo J. LUCENDO. (2022) Nutritional approach to eosinophilic esophagitis: which diet and when. Minerva Gastroenterology 68:1.
Crossref
Crossref
Alfredo J. Lucendo, Cecilio Santander, Edoardo Savarino, Danila Guagnozzi, Isabel Pérez-Martínez, Antonia Perelló, Antonio Guardiola-Arévalo, Jesús Barrio, María Elena Betoré-Glaria, Carolina Gutiérrez-Junquera, Constanza Ciriza de los Ríos, Francesca Racca, Sonia Fernández-Fernández, Leonardo Blas-Jhon, Anne Lund Krarup, Susana de la Riva, Juan E. Naves, Silvia Carrión, Juan Armando Rodríguez Oballe, Natalia García-Morales, Sonsoles Tamarit-Sebastián, Pilar Navarro, Ángel Arias, Emilio J. Laserna-Mendieta, Sergio Casabona-Francés, Teresa Pérez-Fernández, Roland Llerena Castro, Matteo Ghisa, Daria Manie, Gaia Pellegatta, Adolfo Suárez, Javier Alcedo, Paula Gil Simón, María Teresa Palomeque, Teresa Asensio, Alicia Granja-Navacerrada, Lonore Hurtado de Mendoza Guena, Alba Rodríguez Sánchez, Lluïsa Masiques Mas, Raffaella Dainese & Sara Feo-Ortega. (2022) EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therapeutic Advances in Gastroenterology 15, pages 175628482210742.
Crossref
Crossref
Sara Feo-OrtegaAlfredo J. Lucendo. (2022) Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Therapeutic Advances in Gastroenterology 15, pages 175628482110686.
Crossref
Crossref
Laura FranceschiniRaffaele MacchiarelliIvano BivianoAlessandro Farsi. (2021) Eosinophilic Esophagitis Onset Despite Six Years' Treatment With Omalizumab in an Asthmatic Patient: No Protective Effect for Anti-IgE Therapy?. American Journal of Gastroenterology 116:7, pages 1560-1560.
Crossref
Crossref
Emilio J. Laserna-Mendieta, Sergio Casabona, Danila Guagnozzi, Edoardo Savarino, Antonia Perelló, Antonio Guardiola-Arévalo, Jesús Barrio, Isabel Pérez-Martínez, Anne Lund Krarup, Javier Alcedo, Susana de la Riva, Esther Rey-Iborra, Cecilio Santander, Ángel Arias & Alfredo J. Lucendo. (2020) Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Alimentary Pharmacology & Therapeutics 52:5, pages 798-807.
Crossref
Crossref